These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16255047)
1. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Saito M; Fujisawa A; Nishikomori R; Kambe N; Nakata-Hizume M; Yoshimoto M; Ohmori K; Okafuji I; Yoshioka T; Kusunoki T; Miyachi Y; Heike T; Nakahata T Arthritis Rheum; 2005 Nov; 52(11):3579-85. PubMed ID: 16255047 [TBL] [Abstract][Full Text] [Related]
2. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741 [TBL] [Abstract][Full Text] [Related]
3. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases. Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270 [TBL] [Abstract][Full Text] [Related]
4. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411 [TBL] [Abstract][Full Text] [Related]
5. Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment. Rösen-Wolff A; Quietzsch J; Schröder H; Lehmann R; Gahr M; Roesler J Eur J Haematol; 2003 Sep; 71(3):215-9. PubMed ID: 12930324 [TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754 [TBL] [Abstract][Full Text] [Related]
7. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome. Hentgen V; Despert V; Leprêtre AC; Cuisset L; Chevrant-Breton J; Jégo P; Chalès G; Gall EL; Delpech M; Grateau G J Rheumatol; 2005 Apr; 32(4):747-51. PubMed ID: 15801036 [TBL] [Abstract][Full Text] [Related]
8. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies. Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262 [TBL] [Abstract][Full Text] [Related]
9. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Janssen R; Verhard E; Lankester A; Ten Cate R; van Dissel JT Arthritis Rheum; 2004 Oct; 50(10):3329-33. PubMed ID: 15476236 [TBL] [Abstract][Full Text] [Related]
10. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Feldmann J; Prieur AM; Quartier P; Berquin P; Certain S; Cortis E; Teillac-Hamel D; Fischer A; de Saint Basile G Am J Hum Genet; 2002 Jul; 71(1):198-203. PubMed ID: 12032915 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Aróstegui JI; Aldea A; Modesto C; Rua MJ; Argüelles F; González-Enseñat MA; Ramos E; Rius J; Plaza S; Vives J; Yagüe J Arthritis Rheum; 2004 Dec; 50(12):4045-50. PubMed ID: 15593220 [TBL] [Abstract][Full Text] [Related]
12. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy. Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056 [No Abstract] [Full Text] [Related]
14. A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin. Shalev SA; Sprecher E; Indelman M; Hujirat Y; Bergman R; Rottem M Int Arch Allergy Immunol; 2007; 143(3):190-3. PubMed ID: 17284928 [TBL] [Abstract][Full Text] [Related]
15. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Maksimovic L; Stirnemann J; Caux F; Ravet N; Rouaghe S; Cuisset L; Letellier E; Grateau G; Morin AS; Fain O Rheumatology (Oxford); 2008 Mar; 47(3):309-10. PubMed ID: 18174231 [TBL] [Abstract][Full Text] [Related]
16. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene. Matsubayashi T; Sugiura H; Arai T; Oh-Ishi T; Inamo Y Acta Paediatr; 2006 Feb; 95(2):246-9. PubMed ID: 16449034 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Hawkins PN; Lachmann HJ; Aganna E; McDermott MF Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505 [TBL] [Abstract][Full Text] [Related]
18. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Tanaka N; Izawa K; Saito MK; Sakuma M; Oshima K; Ohara O; Nishikomori R; Morimoto T; Kambe N; Goldbach-Mansky R; Aksentijevich I; de Saint Basile G; Neven B; van Gijn M; Frenkel J; Aróstegui JI; Yagüe J; Merino R; Ibañez M; Pontillo A; Takada H; Imagawa T; Kawai T; Yasumi T; Nakahata T; Heike T Arthritis Rheum; 2011 Nov; 63(11):3625-32. PubMed ID: 21702021 [TBL] [Abstract][Full Text] [Related]
19. CIAS1 mutation in a patient with overlap between Muckle-Wells and chronic infantile neurological cutaneous and articular syndromes. Granel B; Philip N; Serratrice J; Ene N; Grateau G; Dodé C; Cuisset L; Disdier P; Berbis P; Delpech M; Weiller PJ Dermatology; 2003; 206(3):257-9. PubMed ID: 12673085 [TBL] [Abstract][Full Text] [Related]
20. Detection of a novel mutation in NLRP3/CIAS1 gene in an Indian child with Neonatal-Onset Multisystem Inflammatory Disease (NOMID). Nair SB; Chavan PP; Athalye AS; Aksentijevich I; Khubchandani RP Clin Rheumatol; 2019 Feb; 38(2):403-406. PubMed ID: 30066283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]